Loomis, Sayles & Company’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-106
Closed -$3K – 996
2022
Q1
$3K Buy
+106
New +$2.82K ﹤0.01% 860

Other funds holding ELAN

Loomis, Sayles & Company's ELAN Position: Q2 2022 in Review

Loomis, Sayles & Company sold out of Elanco Animal Health (ELAN) in Q2 2022, closing a stake of 106 shares — an estimated $3K sold.

Loomis, Sayles & Company first reported a position in ELAN in Q1 2022 and held it in 1 quarter. The position peaked at $3K in Q1 2022. 438 funds tracked by Wall St. Rank hold ELAN as of Q2 2022.

  • Loomis, Sayles & Company reported no remaining Elanco Animal Health position as of Q2 2022 after selling out during the quarter.
  • Loomis, Sayles & Company sold 106 Elanco Animal Health shares in Q2 2022, an estimated $3K.
  • Loomis, Sayles & Company first reported a position in Elanco Animal Health in Q1 2022 and held it in 1 quarter.
  • Loomis, Sayles & Company's Elanco Animal Health position peaked at $3K in Q1 2022.
  • 438 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2022.

Based on Loomis, Sayles & Company's 13F filing for Q2 2022, filed 5 Aug 2022.